Close Topic Options

Ebola Virus - Page 8

A new vaccine has been developed against the Ebola Virus: Vsv-ebov Vaccine For Ebola Virus

Virus Ebola

Researchers Discover New Ebola-fighting Antibodies In Blood Of Outbreak Survivor
Science Related News

A new group of powerful antibodies to fight Ebola virus has been discovered by a team of scientists. The antibodies, isolated from the blood of a survivor of the 2014 Ebola outbreak and the largest panel reported to date, could guide the development of a vaccine or therapeutic against Ebola.
Source

Ebola Virus Health & Special Psychology

Experimental Ebola antibody protects monkeys

Scientists have discovered that a single monoclonal antibody isolated from a human Ebola virus disease survivor protected non-human primates when given as late as five days after lethal Ebola infection. The antibody can now advance to testing in humans as a potential treatment for Ebola virus disease. There are currently no licensed treatments for Ebola infection, which caused more than 11,000 deaths in the 2014-2015 outbreak in West Africa. Ref. Source 4c.

Page 8 Virus Ebola

Confirmation that the Ebola virus persists in the semen of survivors of the epidemic

An international study confirms that Ebola virus persists in the semen of survivors of the epidemic in Guinea, for up to 9 months after their recovery. These results recall the importance of monitoring survivors in order to prevent the risks of new epidemic outbreaks. Ref. Source 8i.

Virus Ebola

Interesting. Maybe that's the reason certain parts of Africa had the virus eliminated only to see it re-surge again right after.

Ebola Virus

Reflecting on Ebola outbreak

To make the world safer against future infectious disease threats, national health systems should be strengthened, the World Health Organization's emergency and outbreak response activities should be consolidated and bolstered, and research and development should be enhanced, says a new article. Ref. Source 3v.

Ebola Virus - Page 8

Scientists pinpoint Ebola's weak spots

Scientists have now have a high-resolution view of exactly how the experimental therapy ZMapp targets Ebola virus. The new study is also the first to show how an antibody in the ZMapp 'drug cocktail' targets a second Ebola virus protein, called sGP, whose vulnerable spots had previously been unknown. Ref. Source 4m.

Ebola Virus Psychology Special & Health - Page 8

Antibodies from Ebola survivors neutralize virus, protect against infection in lab

Antibodies generated from the blood of survivors of Ebola virus disease can strongly neutralize the Ebola virus in the laboratory and protect mice from a lethal viral challenge, report investigators. Ref. Source 3m.